Showing results 1 to 20 of 34
next >
Issue Date | Title | Author(s) |
10-Dec-2015 | Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy | Kovacs, GG; Ferrer, I; Grinberg, LT; Alafuzoff, I; Attems, J, et al |
18-Apr-2016 | alpha-synuclein genetic variability: a biomarker for dementia in parkinson disease | Guella, I; Evans, DM; Szu-Tu, C; Nosova, E; Bortnick, SF, et al |
Jul-2020 | B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis | Reali, C; Magliozzi, R; Roncaroli, F; Nicholas, R; Howell, OW, et al |
7-Dec-2015 | Bringing CLARITY to the human brain: visualization of Lewy pathology in three dimensions | Liu, AKL; Hurry, MED; Ng, OTW; DeFelice, J; Lai, HM, et al |
19-Feb-2018 | C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction | Lautenschlager, J; Stephens, AD; Fusco, G; Strohl, F; Curry, N, et al |
22-Jun-2017 | Chemical probes for visualizing intact animal and human brain tissue | Lai, HM; Ng, W-L; Gentleman, SM; Wu, W; |
Jun-2016 | Clinicopathological investigations of the cholinergic basal forebrain in Lewy body disorders and ageing | Gentleman, Steve; Pearce, Ronald; Chang, Raymond Chuen-Chung; Liu, Alan King Lun; |
22-Jun-2016 | Complement is activated in progressive multiple sclerosis cortical grey matter lesions. | Watkins, LM; Neal, JW; Loveless, S; Michailidou, I; Ramaglia, V, et al |
3-Nov-2015 | Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases. | Ruffmann, C; Calboli, FC; Bravi, I; Gveric, D; Curry, LK, et al |
22-Sep-2015 | Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism | Prusiner, SB; Woerman, AL; Mordes, DA; Watts, JC; Rampersaud, R, et al |
19-Apr-2017 | Free-of-acrylamide SDS-based Tissue Clearing (FASTClear): A novel protocol of tissue clearing for three-dimensional visualisation of human brain tissues | Liu, K; Lai, HM; Chang, RCC; Gentleman, S; , et al |
1-Feb-2021 | Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study | Jabbari, E; Koga, S; Valentino, RR; Reynolds, RH; Ferrari, R, et al |
Aug-2014 | In vivo assessment of pathology in Parkinson’s disease with Positron Emission Tomography | Brooks, David; Simpson, Benjamin; |
1-Apr-2018 | Inflammatory intrathecal profiles and cortical damage in multiple sclerosis | Magliozzi, R; Howell, OW; Nicholas, R; Cruciani, C; Castellaro, M, et al |
13-Jan-2017 | Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation | Tomaz, RA; Harman, JL; Karimlou, D; Weavers, L; Fritsch, L, et al |
25-Jul-2015 | Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease | Niccolini, F; Foltynie, T; Marques, TR; Muhlert, N; Tziortzi, AC, et al |
16-Dec-2016 | Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility. | Martin-Bastida, A; Lao-Kaim, NP; Loane, C; Politis, M; Roussakis, AA, et al |
1-Mar-2019 | Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines | Woerman, AL; Oehler, A; Kazmi, SA; Lee, J; Halliday, GM, et al |
6-Oct-2015 | Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors | Gautier, HOB; Evans, KA; Volbracht, K; James, R; Sitnikov, S, et al |
1-Feb-2021 | Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study | Attems, J; Toledo, JB; Walker, L; Gelpi, E; Gentleman, S, et al |